Great West Life Assurance CO Veracyte, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 25,217 shares of VCYT stock, worth $787,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,217

Previous 23,822 5.86%

Holding current value

$787,779

Previous $812,000 22.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$31.92 - $44.4 $44,528 - $61,938	1,395 Added 5.86%	25,217 $997,000
Q3 2024 Nov 13, 2024	BUY	$21.0 - $35.25 $74,760 - $125,490	3,560 Added 17.57%	23,822 $812,000
Q2 2024 Aug 12, 2024	BUY	$18.86 - $23.55 $227,527 - $284,107	12,064 Added 147.16%	20,262 $439,000
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $11,130 - $15,423	530 Added 6.91%	8,198 $182,000
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $9,978 - $14,512	-506 Reduced 6.19%	7,668 $210,000
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $71,456 - $95,744	3,200 Added 64.33%	8,174 $183,000
Q2 2023 Aug 10, 2023	SELL	$20.96 - $26.99 $8,446 - $10,876	-403 Reduced 7.49%	4,974 $127,000
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $3,478 - $4,713	169 Added 3.25%	5,377 $120,000
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $5,833 - $11,407	381 Added 7.89%	5,208 $124,000
Q3 2022 Nov 01, 2022	BUY	$16.58 - $27.9 $80,031 - $134,673	4,827 New	4,827 $80,000
Q2 2022 Aug 09, 2022	BUY	$15.45 - $29.52 $3,862 - $7,380	250 Added 5.76%	4,593 $91,000
Q1 2022 May 12, 2022	BUY	$21.94 - $42.51 $4,739 - $9,182	216 Added 5.23%	4,343 $127,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $7,614 - $11,349	211 Added 5.39%	4,127 $170,000
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $16,053 - $29,378	361 Added 10.15%	3,916 $209,000
Q3 2020 Nov 17, 2020	SELL	$26.73 - $35.67 $80,216 - $107,045	-3,001 Reduced 45.77%	3,555 $115,000
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $80,216 - $107,045	3,001 Added 84.42%	6,556 $213,000
Q4 2019 Feb 11, 2020	BUY	$20.78 - $29.99 $73,872 - $106,614	3,555 New	3,555 $99,000
Q3 2019 Oct 25, 2019	SELL	$23.87 - $30.93 $89,679 - $116,204	-3,757 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$22.1 - $28.56 $83,029 - $107,299	3,757 New	3,757 $0

Others Institutions Holding VCYT

# of Institutions

339

Shares Held

80.4M

Call Options Held

212K

Put Options Held

18.5K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.24B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Veracyte, Inc. Transaction History